Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-29

Clinical Trial Update: Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated escitalopram for obsessive-compulsive disorder, with results posted after completion (2013).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: Duke University | Conditions: OCD | Phase 2 | Status: COMPLETED | Results posted: 2013-10-29